FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

108794009: Vinorelbine tartrate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
173328013 Vinorelbine tartrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
604768016 Vinorelbine tartrate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
24241000188118 vinorelbine tartrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
849661000172116 tartrate de vinorelbine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vinorelbine tartrate Is a Product containing vinorelbine (medicinal product) false Inferred relationship Some
Vinorelbine tartrate Is a Vinorelbine (substance) false Inferred relationship Some
Vinorelbine tartrate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Mitotic inhibitor (disposition) true Inferred relationship Some
Vinorelbine tartrate Is a Mitotic inhibitor true Inferred relationship Some
Vinorelbine tartrate Is a Vinca alkaloid true Inferred relationship Some
Vinorelbine tartrate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Vinorelbine (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Vinorelbine tartrate 10mg/mL injection solution 1mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Vinorelbine tartrate Inferred relationship Some
Vinorelbine tartrate 10mg/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Vinorelbine tartrate Inferred relationship Some
Vinorelbine 10mg/1mL intravenous solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Vinorelbine tartrate Inferred relationship Some
Vinorelbine 50mg/5mL intravenous solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Vinorelbine tartrate Inferred relationship Some
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for infusion vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Vinorelbine tartrate Inferred relationship Some 1
Product containing precisely vinorelbine (as vinorelbine tartrate) 50 milligram/5 milliliter conventional release solution for infusion vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Vinorelbine tartrate Inferred relationship Some 1
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for infusion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Vinorelbine tartrate Inferred relationship Some 1
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Vinorelbine tartrate Inferred relationship Some 1
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Vinorelbine tartrate Inferred relationship Some 1
Vinorelbine (as vinorelbine tartrate) 30 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Vinorelbine tartrate Inferred relationship Some 1
Product containing precisely vinorelbine (as vinorelbine tartrate) 20 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Vinorelbine tartrate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start